Increased bisecting <i><scp>N</scp></i>‐acetylglucosamine and decreased branched chain glycans of <i><scp>N</scp></i>‐linked glycoproteins in expressed prostatic secretions associated with prostate cancer progression

Abstract

Changes in glycosylation as detected in EPS fluids reflect the clinical status of prostate cancer. Defining these molecular signatures at the glycopeptide level in individual samples could improve current approaches of diagnosis and prognosis.